The prognostic value of anemia in patients with diastolic heart failure

Texas Heart Institute Journal

Volumn 36, Issue 3, 2009, Pages 220-225

  Tehrani, Faramarz ^a   Phan, Anita ^a   Morrissey, Ryan ^a   Chien, Christopher ^a   Rafique, Asim ^a   Schwarz, Ernst R ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

Age factors; Anemia blood complications epidemiology mortality; Diastole; Heart failure blood complications mortality physiopathology; Hemoglobins analysis; Patient readmission; Prevalence; Risk assessment; Survival analysis; Ventricular function left

Indexed keywords

AGED; ANEMIA; ARTICLE; COMORBIDITY; CORRELATION ANALYSIS; DIASTOLIC HEART FAILURE; FEMALE; GERIATRIC PATIENT; HEART LEFT VENTRICLE EJECTION FRACTION; HEMOGLOBIN BLOOD LEVEL; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PREDICTION; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; SURVIVAL TIME;

AGED; AGED, 80 AND OVER; ANEMIA; FEMALE; HEART FAILURE, DIASTOLIC; HEMOGLOBINS; HOSPITALIZATION; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; STROKE VOLUME; TIME FACTORS; VENTRICULAR FUNCTION, LEFT;

EID: 67650448008     PISSN: 07302347     EISSN: 15266702     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Gomez JM, Carrera F. What should the optimal target hemoglobin be? Kidney Int Suppl 2002;(80):39-43.
2. Young JB, Abraham WT, Albert NM, Gattis Stough W, Gheorghiade M, Greenberg BH, et al. Relation of low hemoglobin and anemia to morbidity and mortality in patients hospitalized with heart failure (insight from the OPTIMIZE-HF registry). Am J Cardiol 2008;101(2):223-30.
3. Redondo-Bermejo B, Pascual-Figal DA, Hurtado-Martinez JA, Montserrat-Coll J, Penafiel-Verdu P, Pastor-Perez F, et al. Clinical determinants and prognostic value of hemoglobin in hospitalized patients with systolic heart failure [in Spanish]. Rev Esp Cardiol 2007;60(6):597-606.
4. Kosiborod M, Curtis JP, Wang Y, Smith GL, Masoudi FA, Foody JM, et al. Anemia and outcomes in patients with heart failure: a study from the National Heart Care Project. Arch Intern Med 2005;165(19):2237-44.
5. Go AS, Yang J, Ackerson LM, Lepper K, Robbins S, Massie BM, Shlipak MG. Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: the Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study. Circulation 2006;113(23):2713-23.
6. Shanes JG, Minadeo KN, Moret A, Groner M, Tabaie SA. Statin therapy in heart failure: prognostic effects and potential mechanisms. Am Heart J 2007;154(4):617-23.
7. Chinnaiyan KM, Alexander D, Maddens M, McCullough PA. Curriculum in cardiology: integrated diagnosis and management of diastolic heart failure. Am Heart J 2007;153(2): 189-200.
8. Banerjee P, Banerjee T, Khand A, Clark AL, Cleland JG. Diastolic heart failure: neglected or misdiagnosed? J Am Coll Cardiol 2002;39(1):138-41.
9. Vasan RS, Levy D. Defining diastolic heart failure: a call for standardized diagnostic criteria. Circulation 2000;101(17): 2118-21.
10. Al-Ahmad A, Rand WM, Manjunath G, Konstam MA, Salem DN, Levey AS, Sarnak MJ. Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction. J Am Coll Cardiol 2001;38(4):955-62.
11. Horwich TB, Fonarow GC, Hamilton MA, MacLellan WR, Borenstein J. Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure. J Am Coll Cardiol 2002;39(11):1780-6.
12. Ezekowitz JA, McAlister FA, Armstrong PW. Anemia is common in heart failure and is associated with poor outcomes: insights from a cohort of 12,065 patients with new-onset heart failure. Circulation 2003;107(2):223-5.
13. Kosiborod M, Smith GL, Radford MJ, Foody JM, Krumholz HM. The prognostic importance of anemia in patients with heart failure. Am J Med 2003;114(2):112-9.
14. Mozaffarian D, Nye R, Levy WC. Anemia predicts mortality in severe heart failure: the prospective randomized amlodipine survival evaluation (PRAISE). J Am Coll Cardiol 2003; 41(11):1933-9.
15. Felker GM, Gattis WA, Leimberger JD, Adams KF, Cuffe MS, Gheorghiade M, O'Connor CM. Usefulness of anemia as a predictor of death and rehospitalization in patients with decompensated heart failure. Am J Cardiol 2003;92(5):625-8.
16. Sharma R, Francis DP, Pitt B, Poole-Wilson PA, Coats AJ, Anker SD. Haemoglobin predicts survival in patients with chronic heart failure: a substudy of the ELITE II trial. Eur Heart J 2004;25(12):1021-8.
17. O'Meara E, Clayton T, McEntegart MB, McMurray JJ, Lang CC, Roger SD, et al. Clinical correlates and consequences of anemia in a broad spectrum of patients with heart failure: results of the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Program. Circulation 2006;113(7):986-94.
18. Felker GM, Shaw LK, Stough WG, O'Connor CM. Anemia in patients with heart failure and preserved systolic function. Am Heart J 2006;151(2):457-62.
19. Latado AL, Passos LC, Darze ES, Lopes AA. Comparison of the effect of anemia on in-hospital mortality in patients with versus without preserved left ventricular ejection fraction. Am J Cardiol 2006;98(12):1631-4.
20. Kerzner R, Gage BF, Rich MW. Anemia does not predict mortality in elderly patients with heart failure. Am J Geriatr Cardiol 2007;16(2):92-6.
21. Westenbrink BD, de Boer RA, Voors AA, van Gilst WH, van Veldhuisen DJ. Anemia in chronic heart failure: etiology and treatment options. Curr Opin Cardiol 2008;23(2):141-7.
22. Anand IS. Heart failure and anemia: mechanisms and pathophysiology. Heart Fail Rev 2008;13(4):379-86.
23. Deswal A, Petersen NJ, Feldman AM, Young JB, White BG, Mann DL. Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST). Circulation 2001;103(16):2055-9.
24. Anand IS, Chandrashekhar Y, Ferrari R, Poole-Wilson PA, Harris PC. Pathogenesis of oedema in chronic severe anaemia: studies of body water and sodium, renal function, haemodynamic variables, and plasma hormones. Br Heart J 1993; 70(4):357-62.
25. Anand IS. Anemia and chronic heart failure implications and treatment options. J Am Coll Cardiol 2008;52(7):501-11.
26. Anand IS, Kuskowski MA, Rector TS, Florea VG, Glazer RD, Hester A, et al. Anemia and change in hemoglobin over time related to mortality and morbidity in patients with chronic heart failure: results from Val-HeFT. Circulation 2005;112(8): 1121-7.
27. Anker SD, Coats AJ. Cardiac cachexia: a syndrome with impaired survival and immune and neuroendocrine activation. Chest 1999;115(3):836-47.
28. Chen HH, Lainchbury JG, Senni M, Bailey KR, Redfield MM. Diastolic heart failure in the community: clinical profile, natural history, therapy, and impact of proposed diagnostic criteria. J Card Fail 2002;8(5):279-87.
29. Kitzman DW, Little WC, Brubaker PH, Anderson RT, Hundley WG, Marburger CT, et al. Pathophysiological characterization of isolated diastolic heart failure in comparison to systolic heart failure. JAMA 2002;288(17):2144-50.
30. Zile MR, Baicu CF, Gaasch WH. Diastolic heart failure--abnormalities in active relaxation and passive stiffness of the left ventricle. N Engl J Med 2004;350(19):1953-9.
31. Olivetti G, Quaini F, Lagrasta C, Ricci R, Tiberti G, Capasso JM, Anversa P. Myocyte cellular hypertrophy and hyperplasia contribute to ventricular wall remodeling in anemia-induced cardiac hypertrophy in rats. Am J Pathol 1992;141(1):227-39.
32. Anand I, McMurray JJ, Whitmore J, Warren M, Pham A, Mc-Camish MA, Burton PB. Anemia and its relationship to clinical outcome in heart failure. Circulation 2004;110(2):149-54.
33. Tang WHW, Hobbs RE. Novel strategies for the management of acute decompensated heart failure. Curr Cardiol Rev 2005;1(1):1-5.